These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3967845)

  • 1. Prostaglandin synthesis inhibition reduces platelet aggregation in diabetes mellitus.
    Jones DB; Haitas B; Carter RD; Bown E; Mann JI
    Horm Metab Res; 1985 Jan; 17(1):42-3. PubMed ID: 3967845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus].
    Aguilar Muñoz A; de la Cruz Cortés JP; Martos Crespo F; García Arnés J; de Pablo Molina J; Sánchez de la Cuesta F
    Med Clin (Barc); 1986 May; 86(17):712-5. PubMed ID: 3736161
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin sensitivity of platelet aggregation in diabetes mellitus.
    Albert SG; Hasnain BI; Ritter DG; Joist JH; Mooradian AD
    Diabetes Res Clin Pract; 2005 Nov; 70(2):195-9. PubMed ID: 15894396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostaglandin generation.
    Mehta J; Mehta P
    J Cardiovasc Pharmacol; 1982; 4(4):688-93. PubMed ID: 6181345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aspirin and dipyridamole on platelet function, hematology, and blood chemistry of saturation divers.
    Philp RB; Bennett PB; Andersen JC; Fields GN; McIntyre BA; Francey I; Briner W
    Undersea Biomed Res; 1979 Jun; 6(2):127-46. PubMed ID: 531993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and dipyridamole inhibition of collagen-induced platelet aggregation and release in cynomolgus monkeys.
    Wang ZG; McCann RL; Hagen PO
    Chin Med J (Engl); 1984 Jan; 97(1):19-23. PubMed ID: 6428828
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy.
    De La Cruz P; Guerrero A; Paniego J; Arranz I; Moreno A; Sánchez De La Cuesta F
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):96-101. PubMed ID: 11819026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered platelet function in diabetes mellitus.
    Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
    Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in the effect of aspirin on retinal ischemia, prostanoid synthesis and nitric oxide production in experimental type 1-like diabetes.
    González-Correa JA; Arrebola MM; Muñoz-Marín J; Moreno A; Guerrero A; Arranz I; De La Cuesta FS; De La Cruz JP
    Vascul Pharmacol; 2007; 47(2-3):83-9. PubMed ID: 17581795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral aspirin dose on platelet aggregation and arterial prostacyclin synthesis: studies in humans and rabbits.
    Ellis EF; Jones PS; Wright KF; Richardson DW; Ellis CK
    Adv Prostaglandin Thromboxane Res; 1980; 6():313-5. PubMed ID: 6770601
    [No Abstract]   [Full Text] [Related]  

  • 16. The action of halofenate on platelet shape change and prostaglandin synthesis.
    Favis GR; Colman RW
    J Lab Clin Med; 1978 Jul; 92(1):45-52. PubMed ID: 659964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylbutazone inhibition of equine platelet function.
    Meyers KM; Lindner C; Katz J; Grant B
    Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of metamizol on prostaglandin synthesis in man.
    Frölich JC; Rupp WA; Zapf RM; Badian MJ
    Agents Actions Suppl; 1986; 19():155-66. PubMed ID: 3463174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic, morphometric, and biochemical evolution of vein bypass grafts in a nonhuman primate model. III. Long-term changes and their modification by platelet inhibition with aspirin and dipyridamole.
    Boerboom LE; Olinger GN; Liu TZ; Rodriguez ER; Ferrans VJ; Kissebah AH
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):426-32. PubMed ID: 2308360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.